Carcinoma, Intraductal, Noninfiltrating
-
Subject Areas on Research
- Abbreviated screening protocol for breast MRI: a feasibility study.
- Active Surveillance for DCIS: The Importance of Selection Criteria and Monitoring.
- Altered lymphocyte populations in tumour invaded nodes of breast cancer patients.
- Applying the neoadjuvant paradigm to ductal carcinoma in situ.
- Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer.
- Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ.
- Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment.
- Breast cancer: noninvasive and special situations.
- Breast carcinoma, thyroid carcinoma, and T3 thyrotoxicosis in a male cretin.
- Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
- Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
- Can mammographic findings help discriminate between atypical ductal hyperplasia and ductal carcinoma in situ after needle core biopsy?
- Cancer of the bile ducts associated with ulcerative colitis.
- Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes.
- Characterizing the impact of 25 years of DCIS treatment.
- Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
- Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ.
- Cost comparison of radiation treatment options after lumpectomy for breast cancer.
- Current Trends in the Management of Ductal Carcinoma In Situ.
- Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast.
- Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina White women.
- Ductal carcinoma in situ in BRCA mutation carriers.
- Ductal carcinoma in situ: a review of recent advances.
- Ductal carcinoma in situ: atypical mammographic appearances.
- Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women.
- Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
- Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.
- Evaluation of Pathologic Nipple Discharge: What is the Added Diagnostic Value of MRI?
- Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
- Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice.
- Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
- FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.
- Features of occult invasion in biopsy-proven DCIS at breast MRI.
- Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer.
- Flow cytometric analysis of comedocarcinoma of the prostate: an uncommon histopathological variant of prostatic adenocarcinoma.
- Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.
- HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
- Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients.
- How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS.
- Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.
- Human breast cancer specimens: diffraction-enhanced imaging with histologic correlation--improved conspicuity of lesion detail compared with digital radiography.
- Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
- Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
- Immunoglobulin localization in benign and malignant lesions of the human mammary gland.
- Impact of ductal carcinoma in situ terminology on patient treatment preferences.
- Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
- Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report.
- Increased sectioning of pathologic specimens with ductal carcinoma in situ of the breast: are there clinical consequences?
- Information exchange and decision making in the treatment of Latina and white women with ductal carcinoma in situ.
- Integrative tumor board: recurrent breast cancer or new primary? Case Presentation.
- Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.
- Logical Differential Prediction Bayes Net, improving breast cancer diagnosis for older women.
- Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
- Magnetic resonance imaging captures the biology of ductal carcinoma in situ.
- Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity.
- Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer.
- Maintenance of p53 alterations throughout breast cancer progression.
- Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
- Management of positive sub-areolar/nipple duct margins in nipple-sparing mastectomies.
- Metastatic lesions arising in a Riedel's lobe. Findings from a sulfur colloid liver-spleen scan.
- Microtome shaving radiography: demonstration of loss of mammographic microcalcifications during histologic sectioning.
- Modified radical mastectomy with immediate reconstruction for carcinoma of the breast.
- Molecular markers in ductal carcinoma in situ of the breast.
- Molecular markers of therapeutic resistance in breast cancer.
- Myocardial ischemia associated with high-dose carmustine infusion.
- Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results.
- Nuclear Snail1 and nuclear ZEB1 protein expression in invasive and intraductal human breast carcinomas.
- Oncologic Safety of Nipple-Sparing Mastectomy in Women with Breast Cancer.
- Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ.
- Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis.
- Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
- Papillary carcinoma of the breast: imaging findings.
- Pathologic considerations in the high-risk breast patient.
- Patterns of chromosomal alterations in breast ductal carcinoma in situ.
- Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status.
- Predicting a local recurrence after breast-conserving therapy by gene expression profiling.
- Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features.
- Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response Biomarkers.
- Prioritization of research addressing management strategies for ductal carcinoma in situ.
- Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining.
- Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years.
- Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression.
- Pulmonary changes after primary irradiationfor early breast carcinoma.
- Pure tubular breast carcinoma: a 34 year study of outcomes.
- Quality of Patient Decisions About Breast Reconstruction After Mastectomy.
- Quality of life of Latina and Euro-American women with ductal carcinoma in situ.
- Recurrence after mastectomy for ductal carcinoma in situ.
- Recurrent ductal carcinoma in situ after total mastectomy.
- Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.
- Risk of invasive breast cancer and ductal carcinoma in situ in women with atypical papillary lesions of the breast.
- Satisfaction with treatment decision-making and treatment regret among Latinas and non-Latina whites with DCIS.
- Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ.
- Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
- Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.
- Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ.
- Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ.
- Sonographic detection and sonographically guided biopsy of breast microcalcifications.
- Sonographically guided biopsy of suspicious microcalcifications of the breast: a pilot study.
- Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
- Suspicious breast calcifications undergoing stereotactic biopsy in women ages 70 and over: Breast cancer incidence by BI-RADS descriptors.
- T cell receptor gamma/delta expression on lymphocyte populations of breast cancer patients.
- Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinoma.
- The current clinical value of the DCIS Score.
- The effect of system-level access factors on receipt of reconstruction among Latina and white women with DCIS.
- The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy.
- The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
- Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy.
- Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes.
- Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
- Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers.
- Tumor-associated antigen TAG-72: correlation of expression in primary and metastatic breast carcinoma lesions.
- Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis.
- Validation of an oligo-gene signature for the prognostic stratification of ductal carcinoma in situ (DCIS).
- Volume of resection in patients treated with breast conservation for ductal carcinoma in situ.
- What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS?
- Whole-breast radiation therapy: the long and short of it.